Law Offices of Howard G. Smith announces that a class action has been filed on behalf of investors of Cellular Biomedicine Group Inc. (NASDAQ:CBMG) who purchased shares between June 18, 2014 and April 7, 2015 (the “Class Period”). Purchasers of Cellular Biomedicine Group Inc. (“Cellular Biomedicine”) securities are encouraged to contact Howard G. Smith, Esq. to discuss your legal rights in the pending class action.

The complaint alleges that, among other allegations, the Company used paid stock promoters to achieve its $500 million valuation, but failed to disclose the use of promoters in its regulatory filings. On April 7, 2015, Seeking Alpha published a report on Cellular Biomedicine Group, which asserts that: (i) it has achieved an unsustainable valuation with paid stock promotion; (ii) its “CAR-T” technology has experienced patient deaths and is worthless; (iii) its founders face multiple allegations of dishonesty and are responsible for an alleged illegal offshore stem cell clinic; and (iv) it has multiple accounting and financial integrity issues. On this news, shares of Cellular Biomedicine Group fell sharply, declining $7.00 per share, or nearly 22%, to close on April 7, 2015 at $25.22 per share. The lawsuit seeks to recover damages suffered by investors as a result of the Company’s alleged fraud.

If you suffered a loss in Cellular Biomedicine you have until June 22, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

If you purchased shares of Cellular Biomedicine during the Class Period, contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Law Offices of Howard G. SmithHoward G. Smith, Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com

Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cellular Biomedicine Charts.
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cellular Biomedicine Charts.